Psoriasis News

THE LATEST FROM IPC, INDUSTRY AND OTHERS

Results

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

The spread of COVID-19 in early 2020 brought many concerns and questions about COVID-19 and psoriasis. To help address these concerns dermatologists and researchers created PsoProtect and PsoProtectMe — two global registries aimed at understanding the impact of the pandemic on people with psoriasis. Co-directors of PsoProtect and PsoProtectMe, Catherine Smith and Satveer Mahil, speak about the data collection process and findings from these global registries.

Friday, May 26, 2023

Smiling photos of Drs. de la Cruz and Armijo with the title of the post on a yellow background

Prioritizing the Patient Perspective in Psoriasis Care and Communications

The patient perspective has become even more important in the wake of the pandemic. Here’s how Clinica Dermacross is making it a priority.

Wednesday, January 18, 2023

Revised IPC Statement on COVID-19

This revised statement is based on expert opinion and should be interpreted in the context of local policies and emerging evidence.

Monday, December 19, 2022

PsoProtect Registry Data Update

PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,652 cases.

Wednesday, June 15, 2022

Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 Pandemic

The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.

Wednesday, May 11, 2022

Commentary: Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study

A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.

Tuesday, January 25, 2022

Latin American Case Series

It is not fully understood the impact that COVID-19 has on psoriasis patients.

Wednesday, January 19, 2022

Commentary: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based study

The safety of treatment for immune-mediated diseases like psoriasis during the COVID-19 pandemic is a matter of concern. In an Israeli population-based nested case-control study using the Clalit Health Services database, 3,151 patients with psoriasis that tested positive for SARS-CoV-2 infection were identified.

Wednesday, July 7, 2021

Commentary: Sex differences in immune responses that underlie COVID-19 disease outcomes

Because of the growing body of evidence indicating sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19) infection, the IMPACT Research Team from Yale University investigated sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients.

Monday, May 17, 2021

Commentary: Genetic studies suggest that inflammatory skin diseases increase the risk of COVID-19

An article recently published in the Journal of Allergy and Clinical Immunology suggests that diseases such as psoriasis and atopic dermatitis increase the risk of COVID-19 by approximately 50%. The authors of the study (Lam Tsoi and collaborators, University of Michigan) examined the medical records of 435,000 individuals, 1,115 of whom had been diagnosed with COVID-19.

Monday, February 8, 2021

Commentary: Cytokine inhibitors have a low prevalence of SARS-CoV-2 seroconversion

In a recent publication in Nature Communications1 a team from Friedrich-Alexander University in Germany described their findings from a cross-sectional population cohort study on the prevalence of anti-SARS-CoV-2 immunoglobulin G (IgG) in patients with chronic immune-mediated inflammatory diseases (IMIDs) on cytokine-blocking treatments.

Tuesday, February 2, 2021

Commentary: NPF COVID-19 Task Force Guidance Statements

Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.

Wednesday, January 6, 2021

New Resources

IPC Symposium Report from the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Anti-TNF-a Induced Skin Eruptions in Patients with IBD: Presentation & Clinical Approach in Children

Anti-TNF-a Induced Skin Eruptions in Patients with IBD: Presentation & Clinical Approach in Adults

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.

Name(Required)

First Last

Email(Required)

Country(Required)

Region(Required)

I am a(Required)

CAPTCHA

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Approaching Challenging Patient Interactions with Empathy

How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.

Thursday, May 21, 2026

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.

Friday, May 29, 2026

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Advancing Knowledge. Improving Care.

Psoriasis News

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Prioritizing the Patient Perspective in Psoriasis Care and Communications

Revised IPC Statement on COVID-19

PsoProtect Registry Data Update

Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 Pandemic

Commentary: Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study

Latin American Case Series

Commentary: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based study

Commentary: Sex differences in immune responses that underlie COVID-19 disease outcomes

Commentary: Genetic studies suggest that inflammatory skin diseases increase the risk of COVID-19

Commentary: Cytokine inhibitors have a low prevalence of SARS-CoV-2 seroconversion

Commentary: NPF COVID-19 Task Force Guidance Statements

New Resources

IPC Symposium Report from the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Anti-TNF-a Induced Skin Eruptions in Patients with IBD: Presentation & Clinical Approach in Children

Anti-TNF-a Induced Skin Eruptions in Patients with IBD: Presentation & Clinical Approach in Adults

Subscribe to the IPC Newsletter

Quick Links

Follow us

Approaching Challenging Patient Interactions with Empathy

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Use and Misuse of Systemic Corticosteroids in Psoriasis

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Wednesday, May 27, 2026